Stay updated on Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.

Latest updates to the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov record for the XTEND-1 hemophilia A study is now displayed, including its design, eligibility criteria, outcomes, locations, and results-related information.SummaryDifference89%

- Check11 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check18 days agoChange DetectedA banner announces an NIH website terminology transition, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check25 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error page, replacing the study record content with an error message and basic site chrome. This indicates access is blocked rather than a substantive content update.SummaryDifference20%

Stay in the know with updates to Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.